
Sermorelin
Growth hormone-releasing hormone analogue used in endocrine signalling research.
- Purity:
- ≥99% HPLC
- Sizes available:
- 5 mg – 20 mg
Stabilised GHRH(1-44) analogue studied in adipose tissue distribution research.
Also known as: TH9507, Egrifta
Tesamorelin is a synthetic GHRH(1-44) analogue bearing a trans-3-hexenoyl modification that confers resistance to enzymatic degradation. Published research examines its effects on visceral adipose tissue distribution and IGF-1 axis dynamics.
| Property | Specification |
|---|---|
| Classification | Trans-3-hexenoyl GHRH (1-44) analogue |
| Also known as | TH9507, Egrifta |
| Purity | ≥99% HPLC |
| CAS number | 218949-48-5 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5136 g/mol |
| Vial sizes available | 10 mg, 20 mg |
| Intended use | Supplied after physician review — not an approved medicine |
| Physical form | Lyophilised powder |
| Storage | -20 °C, protected from light |
| Reconstitution | Bacteriostatic water (quoted separately) |
| Testing | HPLC + mass spectrometry, per batch |
| Dispatch | Insulated cold-chain, tracked, from Argentina or the United States |
The CoA for the specific batch you would receive is reviewed during your consultation and ships with the material.
Request this batch CoAFrom that lot's certificate of analysis, not from what the supplier asserts. The certificate names the laboratory that took the measurement, the date, the task number, the method and the purity found. PeptoClinic publishes the full reports uncropped, exactly as the laboratory printed them.
Only after a physician has reviewed your intake, and only as the guidance issued with your order sets out. None of these compounds is approved by the FDA or ANMAT for that use — which is precisely why the review exists, and why no protocol is published here for anyone to apply on their own.
It is the report an analytical laboratory issues on a specific sample. Four things are worth checking: which compound it claims to have measured, by what method (HPLC for purity, mass spectrometry for identity), what figure it found, and whether the task number can be verified against the laboratory. A certificate with no verifiable task number is a picture.
Because there is no single price. Cost turns on quantity, vial size, the documentation the programme needs and the dispatch route. Each compound is quoted in writing after a free, no-obligation technical consultation, normally within one business day.
Compounds on this site are supplied after an intake that a physician reviews one by one. None of them has been evaluated or approved by the FDA, ANMAT or any equivalent authority for the use it is requested for, and nothing on this page is a recommendation to start one on your own judgement. Whether a compound suits a given person is the reviewing physician's decision.
Compliance →
Stabilised GHRH(1-44) analogue studied in adipose tissue distribution research.
No prices are published on this site. Every compound is quoted through a consultation.
Consult about TesamorelinNo payment. No account. No obligation. One business day response.
Request the Certificate of Analysis (CoA)
Growth hormone-releasing hormone analogue used in endocrine signalling research.

Modified GRF(1-29) tetrasubstituted analogue without drug affinity complex.

Selective ghrelin receptor (GHS-R1a) agonist pentapeptide.